| | Clinical characteristics | n = 65 |
| | Age at heart transplant, years, mean ± SD | 53.7 ± 10.1 | | Age at angiography, years, mean ± SD | 63.3 ± 12.4 | | Donor age, years, mean ± SD | 35.7 ± 14.4 | | Donor sex, male, n (%) | 50 (76.9) | | Recipient sex, male, n (%) | 44 (67.7) | | Arterial hypertension, n (%) | 28 (43.1) | | Diabetes mellitus, n (%) | 25 (38.5) | | Hypercholesterolemia, n (%) | 60 (89.6) | | Smoking, n (%) | 1 (1.5) | | History of ischemic cardiomyopathy, n (%) | 26 (40.0) | | History of valvular cardiomyopathy, n (%) | 5 (7.7) | | Other cardiomyopathies, n (%) | 34 (52.3) | | Mycophenolate mofetil, n (%) | 47 (72.3) | | Azathioprine, n (%) | 2 (3.1) | | Calcineurin inhibitors, n (%) | 65 (100) |
|
|
